Stanislav Mičuda
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 13
- Drug-Induced Hepatotoxicity and Protection 7
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 39
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 6
- Hepatology top 10%
- Obstetrics and Gynecology top 10%
-
- Liver Disease Diagnosis and Treatment 19
-
- Hormonal Regulation and Hypertension 8
-
- Pharmacological Effects and Toxicity Studies 7
-
- Pediatric Hepatobiliary Diseases and Treatments 6
- Co-authors
- Jolana CermanováM HrochFrantišek ŠtaudPetr PávekPetr NachtigalEva DoleželováEva BrčákováMartina Čečková
- Cited by
- PharmacologyOncologyBiochemistry
- Journals
- Physiological Research (8 papers)Life Sciences (5 papers)Journal of Gastroenterology and Hepatology (3 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Stanislav Mičuda
94 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 110
- Pharmacology 209
- Oncology 472
- Biochemistry 95
- Hepatology 83
- Obstetrics and Gynecology 72
Countries citing papers authored by Stanislav Mičuda
This map shows the geographic impact of Stanislav Mičuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanislav Mičuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanislav Mičuda more than expected).
Fields of papers citing papers by Stanislav Mičuda
This network shows the impact of papers produced by Stanislav Mičuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanislav Mičuda. The network helps show where Stanislav Mičuda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stanislav Mičuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 4 | |
| 6 | 2020 | 10 | |
| 7 | 2016 | 10 | |
| 8 | 2015 | 20 | |
| 9 | 2015 | 26 | |
| 10 | 2013 | 8 | |
| 11 | 2012 | 18 | |
| 12 | 2012 | 26 | |
| 13 | 2011 | 4 | |
| 14 | 2011 | 7 | |
| 15 | 2011 | 17 | |
| 16 | 2008 | 6 | |
| 17 | 2008 | 8 | |
| 18 | 2007 | 13 | |
| 19 | 2005 | 18 | |
| 20 | 2005 | 1 |
About Stanislav Mičuda
Stanislav Mičuda is a scholar working on Pharmacology, Oncology, Biochemistry, Hepatology and Horticulture, having authored 97 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (39 papers), Liver Disease Diagnosis and Treatment (19 papers), Pharmacogenetics and Drug Metabolism (13 papers), Hormonal Regulation and Hypertension (8 papers), Drug-Induced Hepatotoxicity and Protection (7 papers), Pharmacological Effects and Toxicity Studies (7 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Pediatric Hepatobiliary Diseases and Treatments (6 papers). The work is most often cited by research in Pharmacology (209 citations), Oncology (472 citations), Biochemistry (95 citations), Hepatology (83 citations) and Obstetrics and Gynecology (72 citations). Stanislav Mičuda has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Jolana Cermanová, M Hroch, František Štaud, Petr Pávek, Petr Nachtigal, Eva Doleželová, Eva Brčáková, Martina Čečková, Leoš Fuksa and Jaroslav Mokrý. Their work appears in journals such as Physiological Research, Life Sciences, Journal of Gastroenterology and Hepatology, Pharmacological Research and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.